NANOG and cancer: It is likely that miR-302 signaling pathway regulated by stem cell markers such as Nanog/Oct4/Sox2 during HA-CD44 interaction may be used as a novel therapeutic drug target to downregulate cancer stem cell (CSC) functions and to overcome chemotherapy resistance in cancer cells.